pmc logo image
Transformation of human osteoblast cells to the tumorigenic phenotype by depleted uranium-uranyl chloride.
A C Miller, W F Blakely, D Livengood, T Whittaker, J Xu, J W Ejnik, M M Hamilton, E Parlette, T S John, H M Gerstenberg, and H Hsu
Environ Health Perspect. 1998 August; 106(8): 465–471.
PMCID: PMC1533215
 Is Cited by the Following Articles in this Archive:
Depleted uranium exposure and health effects in Gulf War veterans
Katherine S Squibb and Melissa A McDiarmid
Philos Trans R Soc Lond B Biol Sci. 2006 April 29; 361(1468): 639–648. Published online 2006 March 24. doi: 10.1098/rstb.2006.1823.
PMCID: PMC1569622
In Vitro Immune Toxicity of Depleted Uranium: Effects on Murine Macrophages, CD4+ T Cells, and Gene Expression Profiles
Bin Wan, James T. Fleming, Terry W. Schultz, and Gary S. Sayler
Environ Health Perspect. 2006 January; 114(1): 85–91. Published online 2005 August 17. doi: 10.1289/ehp.8085.
PMCID: PMC1332661
Implanted depleted uranium fragments cause soft tissue sarcomas in the muscles of rats.
Fletcher F Hahn, Raymond A Guilmette, and Mark D Hoover
Environ Health Perspect. 2002 January; 110(1): 51–59.
PMCID: PMC1240693